Revolutionizing Risk-Based Monitoring Through On-Study Analytics, Upcoming Webinar Hosted by Xtalks
In this free webinar, the featured speakers will discuss how risk analysis is becoming increasingly incorporated in clinical monitoring (e.g. traditional clinical monitoring vs. a risk-based monitoring approach). The pros and cons of different approaches to integrate risk assessment into clinical monitoring -- with risk-based monitoring being one of the most advanced approaches -- will be presented. The importance of electronic data collection and real-time analytics in informing risk-based monitoring will also be discussed. Real-world examples to show how risk-based monitoring coupled with analytics empowers clinical study stakeholders will be presented.
TORONTO, Dec. 2, 2020 /PRNewswire-PRWeb/ -- Since being officially condoned by the FDA in 2013, risk-based monitoring (RBM) has progressed to become a viable clinical monitoring technique, leveraging the latest technology to proactively identify challenges to trial safety, data analysis and compliance. With clinical trial resources prioritized by risk, RBM has brought study sponsors, CROs and other stakeholders greater oversight into how trials are conducted.
Could there be a better pathway for RBM – a more strategic approach that can optimize monitoring in real time?
In their upcoming webinar, Biorasi will be discussing a more sophisticated methodology for addressing RBM throughout the clinical trial. By introducing real-time analytics, RBM can empower trial stakeholders to make better decisions related to speed, cost and quality.
As part of this discussion on innovating RBM, Biorasi will be joined by data, analytics and technology partner IBM Watson Health, who will explore the importance of successful electronic data capture (EDC) to inform data management and analysis at all stages of the clinical trial. Biorasi encourages everyone to engage with the future of RBM by joining this webinar.
Join Roberto Silberwasser, VP, Data Sciences & Biometrics, and Geetesh Shrivastava, Director, Clinical Monitoring from Biorasi; along with Rob DiCicco, Deputy Chief Health Officer, and Sebastien Bohn, Offering Manager Lead - IBM Clinical Development, from IBM Watson Health, in the live webinar on Thursday, December 17, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Revolutionizing Risk-Based Monitoring Through On-Study Analytics.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]
SOURCE Xtalks
Share this article